Major Pharmaceuticals Magnesium Delay 34 mg Tablets (NDC 10006-0700-13) provide targeted, delayed-release mineral supplementation engineered to support muscle function, nerve transmission, bone density, and electrolyte balance in institutional healthcare and clinical care environments. Formulated in a 34 mg strength per tablet, the delayed-release delivery mechanism helps optimize absorption while minimizing gastrointestinal discomfort commonly associated with rapid mineral uptake. Packaged in 60-count boxes and distributed in bulk cases of 24 boxes, this product facilitates organized unit-of-use inventory management, routine clinical dietary regimens, and multi-patient administration across hospitals, long-term care facilities, and specialized care units.
